Moreover, Reschke et al. [23] found that HER3 expression is increased in metastatic melanoma compared to that in primary melanoma and that HER3 is associated with poor prognosis suggesting the importance of HER3 in melanoma progression. The gene discussed is ERBB3; the disease is metastatic melanoma.